ESC 365 - Hyperkalaemia in patients with heart failure – Addressing the unmet medical need.

HFA Premium Access

Hyperkalaemia in patients with heart failure – Addressing the unmet medical need.

Session: Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy

Topic: Comorbidities

Speaker: Professor M. Lainscak (Murska Sobota, SI)

Organised by MedEd Global Solutions & University of Lorraine, supported with an educational grant from Vifor Pharma

Event: Heart Failure 2019

Congress Presentation

About the speaker

Professor Mitja Lainscak

General Hospital Murska Sobota, Murska Sobota (Slovenia)

37 presentations

0 follower

4 more presentations in this session

Welcome and introduction - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Access

Slides

Video

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The cardiologist’s perspective.

Speaker: Professor I. Pina (Philadelphia, US)

Access

Slides

Video

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The nephrologist’s perspective.

Speaker: Professor P. Rossignol (Monaco, MC)

Access

Slides

Video

Panel discussion and close - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Speaker: Professor J. Butler (Dallas, US)

Access

Slides

Access the full session

Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy

Speakers: Professor M. Lainscak, Professor F. Zannad, Professor I. Pina, Professor P. Rossignol, Professor J. Butler

Access

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

Hyperkalaemia in patients with heart failure – Addressing the unmet medical need.

About the speaker

Professor Mitja Lainscak

4 more presentations in this session

Welcome and introduction - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The cardiologist’s perspective.

New evidence on hyperkalaemia management in patients with heart failure, resistant hypertension and chronic kidney disease – The nephrologist’s perspective.

Panel discussion and close - Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Access the full session

Management of hyperkalaemia in patients with heart failure – Overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy

About the event

Heart Failure 2019

ESC 365 is supported by